Cargando…
Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?
Immunotherapy has shown great promise in treating various types of malignant tumors. However, some patients with gastrointestinal cancer have been known to experience rapid disease progression after treatment, a situation referred to as hyperprogressive disease (HPD). This minireview focuses on the...
Autores principales: | Wang, Mo-Xuan, Gao, Shu-Yue, Yang, Fan, Fan, Run-Jia, Yang, Qin-Na, Zhang, Tian-Lan, Qian, Nian-Song, Dai, Guang-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537503/ https://www.ncbi.nlm.nih.gov/pubmed/36212599 http://dx.doi.org/10.5306/wjco.v13.i9.729 |
Ejemplares similares
-
Clinical application and research progress of extracellular slow wave recording in the gastrointestinal tract
por: Ding, Fan, et al.
Publicado: (2022) -
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
por: Adashek, Jacob J., et al.
Publicado: (2019) -
Hyperprogression After Immune-Checkpoint Inhibitor Treatment: Characteristics and Hypotheses
por: Zang, Hongjing, et al.
Publicado: (2020) -
Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
por: Shen, Pan, et al.
Publicado: (2021) -
Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
por: Wang, Zhenghang, et al.
Publicado: (2021)